Sugi Predict

Sugi Predict / Compounds / SCHEMBL7182222

SCHEMBL7182222

SCHEMBL7182222

CCCCC(CC)C[PH](=O)c1ccccc1C(=O)c1c(OC)cccc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ LMNA P02545 2/20 0.41
▸ PRSS1 P07477 1/20 0.40
▸ PRSS2 P07478 1/20 0.40
▸ PRSS3 P35030 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ PPARA Q07869 1/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CNR2 P34972 7/20 0.36
▸ CNR1 P21554 5/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182745 0.93 ALDH1A1 (0.41) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7180875 0.92 ALDH1A1 (0.43) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7185607 0.85 ALDH1A1 (0.44) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7181140 0.84 ALDH1A1 (0.43) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7189803 0.82 ALDH1A1 (0.41) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7182837 0.81 ALDH1A1 (0.43) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7188888 0.81 ALDH1A1 (0.40) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7174990 0.80 ALDH1A1 (0.44) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7177163 0.79 ALDH1A1 (0.40) CA2ALDH1A1CYP3A4LMNAPRSS1
SCHEMBL7187534 0.76 CA12 (0.36) CA2ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 CA2 2297/4885ALDH1A1 3416/4885CYP3A4 1652/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 CA2 2346/4885ALDH1A1 3984/4885CYP3A4 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.